Clinical trial Recruiting at 5 sites Phase 4 Interventional Ages 30 and up

Combining Idecalcitol, Whey Protein, and Exercise to Treat Sarcopenia

Official title: Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia:a RCT Trial

Run by Zhejiang Provincial People's Hospital · NCT06537115 · Data updated 2026-11-12

This study is testing whether combining a vitamin, whey protein, and exercise can help people with sarcopenia build muscle and improve their strength.

Quick facts

PhasePhase 4
Study typeInterventional
Ages30 Years and up
SexAll
Enrollment450 (estimated)
SponsorZhejiang Provincial People's Hospital
Academic / other
Locations5 sites (Hangzhou, Zhejiang and 4 other locations)
StatusRecruiting
StartedJune 16, 2024
Main results expectedMay 31, 2026
Study endsMay 31, 2027
Registry record updatedAugust 5, 2024
Trial IDNCT06537115 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 30 and above who meet the diagnostic criteria for sarcopenia and are able to participate in a comprehensive intervention plan.

Probably not a fit

Patients with severe cardiovascular issues, active malignancies, or other significant health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of idecalcitol combined with whey protein powder and exercise on patients with sarcopenia. Participants are randomly assigned to a control group receiving standard interventions or to experimental groups receiving additional whey protein or both whey protein and idecalcitol. The trial lasts for 24 weeks, focusing on improving muscle mass and function in individuals diagnosed with sarcopenia. The study aims to assess the efficacy of these combined interventions in enhancing patient outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly improve muscle strength and overall health in patients suffering from sarcopenia.

How similar studies have gone: Other studies have shown promising results with similar interventions for sarcopenia, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 30 or above;

  * Meeting the diagnostic criteria for sarcopenia according to the definition of AWGS; ③ Able to walk, willing to accept a comprehensive intervention plan, and guarantee to complete the treatment course; ④ Both patients and their families agree to participate in this study and sign the informed consent form.

Exclusion Criteria:

* Resting systolic blood pressure \> 200 mmHg or resting diastolic blood pressure \> 100 mmHg;

  * Severe heart disease: moderate to severe aortic valve stenosis, acute pericarditis, acute myocarditis, myocardial infarction, uncontrollable arrhythmia;

    * Acute stroke within the past 2 years;

      * Severe airway obstruction;

        * Lower limb fractures in the past 1 year or upper limb fractures in the past 6 months;

          * Hypercalcemia (corrected albumin serum calcium \> 2.60 mmol/L);

            * Active malignant tumors; ⑧ Chronic kidney disease stages 5;

              * Mental illness or severe cognitive impairment;

                * Long-term immobilization; ⑪ Other diseases that may interfere with the evaluation of muscle mass, muscle strength, and physical function; ⑫ Unable to cooperate with treatment due to other reasons; ⑬ Life expectancy less than 6 months.

Where it's running

  • The First People's Hospital of Chun'an County
    Hangzhou, Zhejiang, China
    Recruiting
  • Zhejiang Provincial People's Hospital
    Hangzhou, Zhejiang, China
    Recruiting
  • Huzhou Nanxun District People's Hospital
    Huzhou, Zhejiang, China
    Recruiting
  • Xianju People's Hospital
    Taizhou, Zhejiang, China
    Recruiting
  • Dinghai Central Hospital of Zhoushan City
    Zhoushan, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Jianfang Ni, bachelor — Zhejiang Provincial People's Hospital
  • Study coordinator: Jianfeng Tu, Doctor
  • Email: tutu5800@163.com
  • Phone: +86 15925669920

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.